AU2020900632A0 - Antigen-binding molecules and uses thereof - Google Patents

Antigen-binding molecules and uses thereof

Info

Publication number
AU2020900632A0
AU2020900632A0 AU2020900632A AU2020900632A AU2020900632A0 AU 2020900632 A0 AU2020900632 A0 AU 2020900632A0 AU 2020900632 A AU2020900632 A AU 2020900632A AU 2020900632 A AU2020900632 A AU 2020900632A AU 2020900632 A0 AU2020900632 A0 AU 2020900632A0
Authority
AU
Australia
Prior art keywords
antigen
binding molecules
molecules
binding
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
AU2020900632A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Scout Bio, Inc.
Original Assignee
Scout Bio, Inc.
Filing date
Publication date
Application filed by Scout Bio, Inc. filed Critical Scout Bio, Inc.
Publication of AU2020900632A0 publication Critical patent/AU2020900632A0/en
Priority to US17/905,607 priority Critical patent/US20230110287A1/en
Priority to EP21765118.1A priority patent/EP4114856A4/en
Priority to PCT/IB2021/051746 priority patent/WO2021176362A1/en
Pending legal-status Critical Current

Links

AU2020900632A 2020-03-03 2020-03-03 Antigen-binding molecules and uses thereof Pending AU2020900632A0 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
US17/905,607 US20230110287A1 (en) 2020-03-03 2021-03-03 Antigen-binding molecules and uses thereof
EP21765118.1A EP4114856A4 (en) 2020-03-03 2021-03-03 Antigen-binding molecules and uses thereof
PCT/IB2021/051746 WO2021176362A1 (en) 2020-03-03 2021-03-03 Antigen-binding molecules and uses thereof

Publications (1)

Publication Number Publication Date
AU2020900632A0 true AU2020900632A0 (en) 2020-03-19

Family

ID=

Similar Documents

Publication Publication Date Title
TWI799824B (en) Dll3-targeting multispecific antigen-binding molecules and uses thereof
EP4105211A4 (en) Pyrimidoheterocyclic compounds and application thereof
EP3906055A4 (en) Multi-specific protein molecules and uses thereof
EP3913001A4 (en) Anti-cld18a2 nanobody and application thereof
EP3891181A4 (en) Binding molecules against cd3 and uses thereof
EP3906057A4 (en) Anti-tcr antibody molecules and uses thereof
EP3999545A4 (en) Anti-cd73 antibody and application thereof
EP3997230A4 (en) Claudin-6 binding molecules and uses thereof
EP3794027A4 (en) Optimized gp41-binding molecules and uses thereof
EP4058483A4 (en) Anti-tcr antibody molecules and uses thereof
EP4039708A4 (en) Anti-cll1 antibody and application thereof
EP3740496A4 (en) Proteinaceous molecules and uses therefor
EP3917313A4 (en) Molecules and their derivatives directed against cd45
EP4071172A4 (en) Anti-lilrb1 antibody and uses thereof
EP4001308A4 (en) Anti-tigit antibodies and application thereof
EP3980563A4 (en) Ntrk fusion molecules and uses thereof
AU2022242135A1 (en) Anti-tau antibodies and uses thereof
EP3958867A4 (en) Small molecule bromodomain inhibitors and uses thereof
EP3946431A4 (en) Modified hemoglobin molecules and uses thereof
EP3753956A4 (en) Antigen-binding molecule and combination
AU2022298850A1 (en) Anti-ccr8 antibodies and uses thereof
AU2022340808A1 (en) Antigen-binding molecules and uses thereof
EP4114856A4 (en) Antigen-binding molecules and uses thereof
EP3911680A4 (en) Lilrb3-binding molecules and uses therefor
AU2020900632A0 (en) Antigen-binding molecules and uses thereof